Exploring the impact of a celebrity health announcement on public awareness
the ONA take:
Breast cancer treatment options received considerable media attention when Angelina Jolie revealed she had undergone prophylactic double mastectomy for BRCA1 positivity.
In this first study of media-related impact on public awareness, these authors surveyed two female population-matched cohorts of 1,000 participants each, ages 18 to 65 years, in two polls. Poll 1 was taken in March 2013, before Ms. Jolie’s announcement in May 2013; poll 2 was taken in June 2013, after the announcement.
The authors report a significant increase in awareness of reconstructive breast surgery after breast cancer-related mastectomy. In particular, awareness of autologous tissue and single-stage reconstructions was higher in poll 2, with approximately 20% of women in poll 2 indicating that the media coverage affected their interest in the disease.
This prospective study demonstrated a statistically significant impact of a celebrity announcement on public awareness of breast cancer treatment options. To the best of the authors’ knowledge, theirs is the first study to do so.
The results highlight the importance of media-related impact in improving public awareness of a specific disease.
Breast cancer treatment options received considerable media attention when Angelina Jolie revealed she had undergone double mastectomy.
- Novel Colonoscopy Prep Is Poised to Improve Screening Rates for Colon Cancer
- PPIs Negatively Impact Outcomes of Patients Treated With Capecitabine
- How Physical Changes From Breast Cancer Affect Self-Image: Considerations for Clinicians
- Clinical Use of Cabozantinib in the Treatment of Advanced Kidney Cancer: Efficacy, Safety, and Patient Selection
- Panobinostat Modestly Improves OS in Relapsed Multiple Myeloma
- Overall Benefits of Vaporized Nicotine Products Outweigh Harms, Says International Panel of Experts
- Sugar and Cancer: Mitigating the Affects of Diet on Cancer
- Nurse Residency Programs Can Impact Oncology Nursing Practice, Outcomes
- Implementing a Distress Screening Process for Cancer Patients
- Initiating Palliative Care in the Emergency Department
- Pseudohyperkalemia: False Potassium Levels Occur in a Patient With Lymphoma
- Atezolizumab Granted FDA Approval for Specific Cases of NSCLC
- Low-Dose Sublingual Fentanyl Safe, Effective in Patients Receiving Lower Opioid Doses
- High U.S. Economic Burden for Vaccine-Preventable Diseases
- Short-Term Intervention May Have Long-term Diet Effect in Hispanic Breast Cancer Survivors
Sign Up for Free e-newsletters
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|